Associated Papers
Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study.
Díaz-Villamarín X et al.
Pharmaceutics, 2024
Influence of Single-Nucleotide Polymorphisms on Clinical Outcomes of Capecitabine-Based Chemotherapy in Colorectal Cancer Patients: A Systematic Review.
Cura Y et al.
Cancers, 2023
The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidines.
De Mattia E et al.
Cancer Drug Resistance (alhambra, Calif.), 2019
Select a paper to view details